Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment
Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.
Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice
The authors found no consistent pattern in the concordance between CER evidence and subsequent utilization patterns.
